Reuslts about the use of gemcitabine puls irinotecan as frist line in the treatment of pancreatic cancer are discussed
Gemcitabine plus irinotecan as first line weekly therapy in locally advanced and/or metastatic pancreatic cancer / Pantalone D, Bechi P, Taddei A, Ardu U, Grifoni R, Molinara E, Tonelli P, Neri B,. - STAMPA. - Proceedings:(2008), pp. 189-189. ( 2008 GASTROINTESTINAL CANCERS SYMPOSIUM -SCIENCES AND MULTIDICIPLINARY MANAGEMENT OF GI MALIGNANCIES-ASCO, ASTRO, SSO Orlado (Florida USA) 27-27 January 2008).
Gemcitabine plus irinotecan as first line weekly therapy in locally advanced and/or metastatic pancreatic cancer
Pantalone D
;Bechi P;Taddei A;ARDU, UBALDO;Molinara E;Tonelli P;Neri B
2008
Abstract
Reuslts about the use of gemcitabine puls irinotecan as frist line in the treatment of pancreatic cancer are discussedFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



